XBP develops and sells portable hemodialysis equipment and related treatment platforms.
Founded in 2018 in Shanghai, China, XBP, also known as Shanghai Xinguang Bio-pharmaceutical Co., Ltd., develops, manufactures and sells hemodialysis devices. Its portable dialysis platforms use dialysate regeneration and pneumatic diaphragm pump technologies and are designed for hemodialysis, peritoneal dialysis and CRRT. The second-generation prototype has completed animal testing. The company raised Series A1 funding in December 2025 and has more than 7 international PCT patents.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in